Latanoprost

Cat. No.: 0225LY-1111

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Latanoprost is an analogue of prostaglandin F2alpha and a selective FP receptor agonist utilized for its ability to reduce ocular hypertension.

Synonym: Xalatan; PHXA41; 130209-82-4; PHXA-41; XA41; PhXA 41; Latanoprostum; XA-41; Propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate; Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate; XA 41; Latanoprost, (+/-)-; 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-, 1-methylethyl ester, (5Z)-; propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate

CAS No.: 130209-82-4

Compound CID: 5311221

Formula: C₂₆H₄₀O₅

Formula Weight: 432.59

Specification

Relative Density: 1.093 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Latanoprost can be used in ophthalmology research to study the reduction of intraocular pressure through prostaglandin F2-alpha receptor agonism.